미용 의료 관광 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2024-2032년)

Growth Factors of cosmetic medical tourism Market

The global cosmetic medical tourism market is witnessing rapid growth as an increasing number of individuals travel abroad to undergo aesthetic procedures at lower costs and with access to highly skilled surgeons. According to the 2024 industry analysis, the global cosmetic medical tourism market was valued at USD 5.90 billion in 2024 and is projected to reach USD 7.23 billion in 2025, eventually expanding to USD 31.53 billion by 2032. This represents a strong CAGR of 23.4% throughout the forecast period. In 2024, Europe led the global market, accounting for 34.92% of total revenue, supported by a top-tier healthcare system, competitive treatment prices, and an increasing influx of international cosmetic surgery patients.

Cosmetic medical tourism involves traveling abroad for cosmetic procedures such as breast augmentation, rhinoplasty, liposuction, Botox treatments, and facelifts. Rising beauty consciousness, social media influence, and increasing affordability of international treatments continue to attract millions of patients worldwide. For example, according to the International Society of Aesthetic Plastic Surgery (ISAPS), Germany recorded 80,519 liposuctions and 421,684 Botox procedures in 2023, demonstrating the strong global demand for aesthetic enhancements.

Market Dynamics

Market Drivers

A major factor driving global market growth is the rapid expansion of healthcare infrastructure in emerging countries such as Turkey, Thailand, India, and South Korea. Healthcare providers in these nations are investing heavily in advanced technologies, increasing bed capacity, recruiting highly skilled specialists, and enhancing overall service quality to attract international patients. As a result, these countries now rank among the most preferred medical tourism destinations for procedures such as breast augmentation, eyelid surgery, liposuction, and non-invasive treatments like dermal fillers and Botox.

Globally, demand for cosmetic procedures continues to rise sharply. In 2023 alone, ISAPS reported 2.2 million liposuctions and 1.1 million rhinoplasties, highlighting the worldwide popularity of both surgical and non-surgical enhancements. Lower treatment costs in developing nations, combined with high-quality surgical outcomes, are expected to further boost patient inflow over the coming years.

Market Restraints

Despite significant growth, the market faces challenges related to post-operative complications and the lack of adequate follow-up care. Many patients return home immediately after surgery, limiting access to the surgeon who performed the procedure. This gap can lead to complications such as infections, sepsis, or poor surgical outcomes. As noted by Patient Safety Learning in 2025, U.K. patients returning from low-cost cosmetic surgeries abroad have been increasingly affected by dangerous post-surgical infections and superbugs.

Additionally, inconsistent international post-operative standards and the rising number of bundled "package deals" for surgeries increase safety risks, discouraging some patients from seeking cosmetic treatments abroad.

Market Opportunities

Governments and healthcare organizations worldwide are actively launching awareness campaigns to promote safe and informed decision-making regarding cosmetic treatments. For example, the American Cosmetic Association organized Cosmetic & Plastic Surgery Awareness Day to educate the public about cosmetic surgery benefits and risks. Such initiatives create new opportunities by promoting transparency, safety, and consumer confidence in international aesthetic services.

Market Challenges

A major challenge is the high cost of cosmetic procedures in developed countries, which significantly limits domestic adoption and pushes patients toward overseas treatment options. For instance, in the U.K., breast implant surgeries can cost between USD 3,831 and USD 11,494, whereas in Turkey the cost ranges from USD 3,950 to USD 4,491, including surgery and aftercare. Botox prices also remain far more affordable internationally, driving patient migration.

Regional Outlook

Europe

Europe dominated the market in 2024, reaching USD 2.06 billion and representing 34.9% of global demand. Countries such as Spain, Poland, Greece, and the Czech Republic are top cosmetic surgery destinations due to affordable pricing and highly skilled medical professionals.

North America

North America held the second-largest share in 2024, driven by advanced healthcare systems, high practitioner concentration, and new product launches such as MENTOR MemoryGel Enhance Breast Implants in 2025.

Asia Pacific

Asia Pacific is expected to grow at the highest CAGR during 2025-2032. South Korea alone attracts over 100,000 international cosmetic patients annually, driven by K-beauty trends and cutting-edge aesthetic technologies.

Latin America & Middle East-Africa

These regions continue to grow steadily due to increasing numbers of cosmetic treatment providers and enhanced access to affordable aesthetic services.

Conclusion

With the market rising from USD 5.90 billion in 2024 to USD 31.53 billion by 2032, cosmetic medical tourism is poised for exceptional global expansion. Lower treatment costs, improved healthcare infrastructure, and growing awareness of aesthetic procedures will continue to drive market momentum across all major regions.

Segmentation

By Service Type

• Invasive Cosmetic Procedures
  • Breast Augmentation
  • Liposuction
  • Eyelid Surgery
  • Abdominoplasty
  • Rhinoplasty
  • Others
• Non-invasive Cosmetic Procedures
  • Botulinum Toxin
  • Hyaluronic Acid
  • Hair Removal
  • Non-surgical Fat Reduction
  • Photo Rejuvenation
  • Others

By Age Group

• 18 Years & Younger
• 19 to 34 Years
• 35 to 50 Years
• 51 to 64 Years
• 65 Years and Above

By Service Provider

• Public
• Private

By Region

• North America (By Service Type, By Age Group, By Service Provider, and By Country)
  • U.S.
  • Canada
• Europe (By Service Type, By Age Group, By Service Provider, and By Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Service Type, By Age Group, By Service Provider, and By Country/Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Service Type, By Age Group, By Service Provider, and By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Service Type, By Age Group, By Service Provider, and By Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Statistics on Cosmetic Procedures - by Key Countries/Sub-regions, 2024
• 4.2. Overview of Healthcare Expenditure -by Key Countries/Sub-regions, 2024
• 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Cosmetic Medical Tourism Market Analysis, Insights and Forecast, 2019-2032

• 5.1. Market Analysis, Insights and Forecast - By Service Type
  • 5.1.1. Invasive Cosmetic Procedures
    • 5.1.1.1. Breast Augmentation
    • 5.1.1.2. Liposuction
    • 5.1.1.3. Eyelid Surgery
    • 5.1.1.4. Abdominoplasty
    • 5.1.1.5. Rhinoplasty
    • 5.1.1.6. Others
  • 5.1.2. Non-invasive Cosmetic Procedures
    • 5.1.2.1. Botulinum Toxin
    • 5.1.2.2. Hyaluronic Acid
    • 5.1.2.3. Hair Removal
    • 5.1.2.4. Non-surgical Fat Reduction
    • 5.1.2.5. Photo Rejuvenation
    • 5.1.2.6. Others
• 5.2. Market Analysis, Insights and Forecast - By Age Group
  • 5.2.1. 18 Years & Younger
  • 5.2.2. 19 to 34 Years
  • 5.2.3. 35 to 50 Years
  • 5.2.4. 51 to 64 Years
  • 5.2.5. 65 Years and Above
• 5.3. Market Analysis, Insights and Forecast - By Service Provider
  • 5.3.1. Public
  • 5.3.2. Private
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Cosmetic Medical Tourism Market Analysis, Insights and Forecast, 2019-2032

• 6.1. Market Analysis, Insights and Forecast - By Service Type
  • 6.1.1. Invasive Cosmetic Procedures
    • 6.1.1.1. Breast Augmentation
    • 6.1.1.2. Liposuction
    • 6.1.1.3. Eyelid Surgery
    • 6.1.1.4. Abdominoplasty
    • 6.1.1.5. Rhinoplasty
    • 6.1.1.6. Others
  • 6.1.2. Non-invasive Cosmetic Procedures
    • 6.1.2.1. Botulinum Toxin
    • 6.1.2.2. Hyaluronic Acid
    • 6.1.2.3. Hair Removal
    • 6.1.2.4. Non-surgical Fat Reduction
    • 6.1.2.5. Photo Rejuvenation
    • 6.1.2.6. Others
• 6.2. Market Analysis, Insights and Forecast - By Age Group
  • 6.2.1. 18 Years & Younger
  • 6.2.2. 19 to 34 Years
  • 6.2.3. 35 to 50 Years
  • 6.2.4. 51 to 64 Years
  • 6.2.5. 65 Years and Above
• 6.3. Market Analysis, Insights and Forecast - By Service Provider
  • 6.3.1. Public
  • 6.3.2. Private
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Cosmetic Medical Tourism Market Analysis, Insights and Forecast, 2019-2032

• 7.1. Market Analysis, Insights and Forecast - By Service Type
  • 7.1.1. Invasive Cosmetic Procedures
    • 7.1.1.1. Breast Augmentation
    • 7.1.1.2. Liposuction
    • 7.1.1.3. Eyelid Surgery
    • 7.1.1.4. Abdominoplasty
    • 7.1.1.5. Rhinoplasty
    • 7.1.1.6. Others
  • 7.1.2. Non-invasive Cosmetic Procedures
    • 7.1.2.1. Botulinum Toxin
    • 7.1.2.2. Hyaluronic Acid
    • 7.1.2.3. Hair Removal
    • 7.1.2.4. Non-surgical Fat Reduction
    • 7.1.2.5. Photo Rejuvenation
    • 7.1.2.6. Others
• 7.2. Market Analysis, Insights and Forecast - By Age Group
  • 7.2.1. 18 Years & Younger
  • 7.2.2. 19 to 34 Years
  • 7.2.3. 35 to 50 Years
  • 7.2.4. 51 to 64 Years
  • 7.2.5. 65 Years and Above
• 7.3. Market Analysis, Insights and Forecast - By Service Provider
  • 7.3.1. Public
  • 7.3.2. Private
• 7.4. Market Analysis, Insights and Forecast - By County/ Sub-region
  • 7.4.1. Germany
  • 7.4.2. U.K.
  • 7.4.3. France
  • 7.4.4. Italy
  • 7.4.5. Spain
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Cosmetic Medical Tourism Market Analysis, Insights and Forecast, 2019-2032

• 8.1. Market Analysis, Insights and Forecast - By Service Type
  • 8.1.1. Invasive Cosmetic Procedures
    • 8.1.1.1. Breast Augmentation
    • 8.1.1.2. Liposuction
    • 8.1.1.3. Eyelid Surgery
    • 8.1.1.4. Abdominoplasty
    • 8.1.1.5. Rhinoplasty
    • 8.1.1.6. Others
  • 8.1.2. Non-invasive Cosmetic Procedures
    • 8.1.2.1. Botulinum Toxin
    • 8.1.2.2. Hyaluronic Acid
    • 8.1.2.3. Hair Removal
    • 8.1.2.4. Non-surgical Fat Reduction
    • 8.1.2.5. Photo Rejuvenation
    • 8.1.2.6. Others
• 8.2. Market Analysis, Insights and Forecast - By Age Group
  • 8.2.1. 18 Years & Younger
  • 8.2.2. 19 to 34 Years
  • 8.2.3. 35 to 50 Years
  • 8.2.4. 51 to 64 Years
  • 8.2.5. 65 Years and Above
• 8.3. Market Analysis, Insights and Forecast - By Service Provider
  • 8.3.1. Public
  • 8.3.2. Private
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.4.1. China
  • 8.4.2. India
  • 8.4.3. Japan
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Cosmetic Medical Tourism Market Analysis, Insights and Forecast, 2019-2032

• 9.1. Market Analysis, Insights and Forecast - By Service Type
  • 9.1.1. Invasive Cosmetic Procedures
    • 9.1.1.1. Breast Augmentation
    • 9.1.1.2. Liposuction
    • 9.1.1.3. Eyelid Surgery
    • 9.1.1.4. Abdominoplasty
    • 9.1.1.5. Rhinoplasty
    • 9.1.1.6. Others
  • 9.1.2. Non-invasive Cosmetic Procedures
    • 9.1.2.1. Botulinum Toxin
    • 9.1.2.2. Hyaluronic Acid
    • 9.1.2.3. Hair Removal
    • 9.1.2.4. Non-surgical Fat Reduction
    • 9.1.2.5. Photo Rejuvenation
    • 9.1.2.6. Others
• 9.2. Market Analysis, Insights and Forecast - By Age Group
  • 9.2.1. 18 Years & Younger
  • 9.2.2. 19 to 34 Years
  • 9.2.3. 35 to 50 Years
  • 9.2.4. 51 to 64 Years
  • 9.2.5. 65 Years and Above
• 9.3. Market Analysis, Insights and Forecast - By Service Provider
  • 9.3.1. Public
  • 9.3.2. Private
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Cosmetic Medical Tourism Market Analysis, Insights and Forecast, 2019-2032

• 10.1. Market Analysis, Insights and Forecast - By Service Type
  • 10.1.1. Invasive Cosmetic Procedures
    • 10.1.1.1. Breast Augmentation
    • 10.1.1.2. Liposuction
    • 10.1.1.3. Eyelid Surgery
    • 10.1.1.4. Abdominoplasty
    • 10.1.1.5. Rhinoplasty
    • 10.1.1.6. Others
  • 10.1.2. Non-invasive Cosmetic Procedures
    • 10.1.2.1. Botulinum Toxin
    • 10.1.2.2. Hyaluronic Acid
    • 10.1.2.3. Hair Removal
    • 10.1.2.4. Non-surgical Fat Reduction
    • 10.1.2.5. Photo Rejuvenation
    • 10.1.2.6. Others
• 10.2. Market Analysis, Insights and Forecast - By Age Group
  • 10.2.1. 18 Years & Younger
  • 10.2.2. 19 to 34 Years
  • 10.2.3. 35 to 50 Years
  • 10.2.4. 51 to 64 Years
  • 10.2.5. 65 Years and Above
• 10.3. Market Analysis, Insights and Forecast - By Service Provider
  • 10.3.1. Public
  • 10.3.2. Private
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.4.1. South Africa
  • 10.4.2. GCC
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2024)
• 11.2. Company Profiles
  • 11.2.1. Apollo Hospitals Enterprise Ltd.
    • 11.2.1.1. Overview
    • 11.2.1.2. Service
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Azurite Medical & Wellness
    • 11.2.2.1. Overview
    • 11.2.2.2. Service
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Bangkok Hospital
    • 11.2.3.1. Overview
    • 11.2.3.2. Service
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Grand Plastic Surgery
    • 11.2.4.1. Overview
    • 11.2.4.2. Service
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Fortis Healthcare
    • 11.2.5.1. Overview
    • 11.2.5.2. Service
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. KPJ Healthcare Berhad
    • 11.2.6.1. Overview
    • 11.2.6.2. Service
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Livonta Global
    • 11.2.7.1. Overview
    • 11.2.7.2. Service
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Asthetica
    • 11.2.8.1. Overview
    • 11.2.8.2. Service
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Gleneagles Healthcare India Private Limited
    • 11.2.9.1. Overview
    • 11.2.9.2. Service
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Dhanwantari's Chrysalis
    • 11.2.10.1. Overview
    • 11.2.10.2. Service
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)
  • 11.2.11. The Esthetic Clinics
    • 11.2.11.1. Overview
    • 11.2.11.2. Service
    • 11.2.11.3. SWOT Analysis
    • 11.2.11.4. Recent Developments
    • 11.2.11.5. Strategies
    • 11.2.11.6. Financials (Based on Availability)
  • 11.2.12. Medical Care Hungary Kft
    • 11.2.12.1. Overview
    • 11.2.12.2. Service
    • 11.2.12.3. SWOT Analysis
    • 11.2.12.4. Recent Developments
    • 11.2.12.5. Strategies
    • 11.2.12.6. Financials (Based on Availability)
  • 11.2.13. Nera Clinic
    • 11.2.13.1. Overview
    • 11.2.13.2. Service
    • 11.2.13.3. SWOT Analysis
    • 11.2.13.4. Recent Developments
    • 11.2.13.5. Strategies
    • 11.2.13.6. Financials (Based on Availability)